Latest Insider Transactions at Pacific Biosciences Of California, Inc. (PACB)
This section provides a real-time view of insider transactions for Pacific Biosciences Of California, Inc. (PACB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 02
2023
|
Susan G. Kim Officer |
BUY
Grant, award, or other acquisition
|
Direct |
164,200
+33.32%
|
-
|
Mar 02
2023
|
Michele Farmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,100
+31.01%
|
-
|
Mar 02
2023
|
Jeff Eidel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
164,200
+25.87%
|
-
|
Feb 17
2023
|
Susan G. Kim Officer |
SELL
Open market or private sale
|
Direct |
907
-0.55%
|
$9,070
$10.27 P/Share
|
Feb 17
2023
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
1,530
-0.24%
|
$15,300
$10.27 P/Share
|
Jan 10
2023
|
Mark Van Oene Officer |
SELL
Open market or private sale
|
Direct |
26,722
-4.0%
|
$240,498
$9.53 P/Share
|
Dec 01
2022
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
45,000
-6.54%
|
$450,000
$10.84 P/Share
|
Sep 29
2022
|
Susan G. Kim Officer |
SELL
Open market or private sale
|
Direct |
12,968
-7.35%
|
$64,840
$5.61 P/Share
|
Sep 15
2022
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
91,307
-11.71%
|
$456,535
$5.78 P/Share
|
Aug 25
2022
|
Mark Van Oene Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+31.01%
|
-
|
Aug 16
2022
|
Jeff Eidel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+49.95%
|
-
|
Jun 10
2022
|
Marshall Mohr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+36.84%
|
$35,000
$1.83 P/Share
|
May 18
2022
|
Michele Farmer Officer |
SELL
Open market or private sale
|
Direct |
3,573
-5.59%
|
$17,865
$5.55 P/Share
|
Mar 17
2022
|
William W. Ericson Director |
BUY
Other acquisition or disposition
|
Direct |
1,268
+48.69%
|
-
|
Mar 17
2022
|
William W. Ericson Director |
SELL
Other acquisition or disposition
|
Indirect |
4,848,397
-100.0%
|
-
|
Mar 02
2022
|
Christian O Henry Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,500
+12.11%
|
-
|
Mar 02
2022
|
Mark Van Oene Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,500
+16.53%
|
-
|
Mar 02
2022
|
Peter Fromen Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+20.81%
|
-
|
Mar 02
2022
|
Susan G. Kim Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+18.61%
|
-
|
Mar 02
2022
|
Michele Farmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+26.47%
|
-
|
Feb 17
2022
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
2,122
-0.31%
|
$23,342
$11.09 P/Share
|
Feb 17
2022
|
Susan G. Kim Officer |
SELL
Open market or private sale
|
Direct |
1,062
-0.78%
|
$11,682
$11.06 P/Share
|
Feb 16
2022
|
Kathy Ordonez Director |
SELL
Open market or private sale
|
Direct |
3,280
-14.99%
|
$36,080
$11.5 P/Share
|
Jan 14
2022
|
Marshall Mohr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$75,000
$3.57 P/Share
|
Jan 11
2022
|
Peter Fromen Officer |
SELL
Open market or private sale
|
Direct |
19,720
-12.33%
|
$276,080
$14.3 P/Share
|
Jan 11
2022
|
Mark Van Oene Officer |
SELL
Open market or private sale
|
Direct |
41,480
-12.38%
|
$580,720
$14.23 P/Share
|
Sep 29
2021
|
Susan G. Kim Officer |
SELL
Open market or private sale
|
Direct |
20,272
-12.97%
|
$506,800
$25.75 P/Share
|
Sep 16
2021
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
90,520
-11.83%
|
$2,353,520
$26.91 P/Share
|
May 25
2021
|
William W. Ericson Director |
SELL
Open market or private sale
|
Direct |
37,500
-98.8%
|
$975,000
$26.15 P/Share
|
May 25
2021
|
William W. Ericson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+45.0%
|
$225,000
$6.21 P/Share
|
May 17
2021
|
Michele Farmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+50.0%
|
-
|
Feb 26
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
234,246
-5.71%
|
$7,495,872
$32.06 P/Share
|
Feb 26
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
234,246
+7.13%
|
$1,405,476
$6.29 P/Share
|
Feb 25
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
339,377
-5.37%
|
$11,199,441
$33.42 P/Share
|
Feb 25
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
339,377
+9.53%
|
$2,036,262
$6.29 P/Share
|
Feb 24
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
266,427
-6.59%
|
$9,591,372
$36.96 P/Share
|
Feb 24
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
266,427
+6.13%
|
$1,598,562
$6.25 P/Share
|
Feb 23
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
373,321
-5.02%
|
$12,319,593
$33.96 P/Share
|
Feb 23
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
373,321
+6.5%
|
$1,866,605
$5.53 P/Share
|
Feb 22
2021
|
Eric Schaefer Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,842
-4.16%
|
$149,838
$39.2 P/Share
|
Feb 22
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
229,127
-4.66%
|
$8,935,953
$39.15 P/Share
|
Feb 22
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
229,127
+4.46%
|
$1,145,635
$5.53 P/Share
|
Feb 16
2021
|
Susan G. Kim Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,300
+3.87%
|
-
|
Feb 16
2021
|
Christian O Henry Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+1.92%
|
-
|
Feb 16
2021
|
Eric Schaefer Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,050
+5.19%
|
-
|
Feb 16
2021
|
Kathy Ordonez Director |
SELL
Open market or private sale
|
Direct |
220,771
-45.05%
|
$10,597,008
$48.35 P/Share
|
Feb 16
2021
|
Kathy Ordonez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
185,879
+17.03%
|
$929,395
$5.18 P/Share
|
Feb 12
2021
|
William W. Ericson Director |
BUY
Other acquisition or disposition
|
Direct |
68
+50.0%
|
-
|
Feb 12
2021
|
William W. Ericson Director |
SELL
Other acquisition or disposition
|
Indirect |
750,000
-13.4%
|
-
|
Feb 12
2021
|
David Botstein Director |
SELL
Open market or private sale
|
Direct |
160,000
-98.39%
|
$7,840,000
$49.85 P/Share
|